/16/5c/26d665d064c3447565ab6c7c6c47.png "LYL BIOTIC Drops drops, 10 ml")
/4a/14/90e5d178e5f16516ed863a0288bd.png "LYL BIOTIC Drops drops, 10 ml")
/7f/58/d6e783d9d4b40438171b4c257c36.png "LYL BIOTIC Drops drops, 10 ml")
/f1/e5/f6045181a1d87736595c0908dbac.png "LYL BIOTIC Drops drops, 10 ml")
The composition is recognized by doctors. The Digestive Diseases Society recognizes the combination of LYLBIOTIC Drops with lacto and bifidobacteria, confirming it with the Digestive Diseases Society logo.
LYLBIOTIC Drops combines the particularly valuable for infants and children strains of Lacticaseibacillus rhamnosus GG, Limosilactobacillus reuteri LRE02 and Bifidobacterium breve BR03™️ bacteria.
Dietary supplement (probiotics). The daily dose contains 1 billion microencapsulated lactic acid and bifidobacteria, which are naturally found in the intestinal microbiota.
The effectiveness of the product is ensured by 2 innovative technologies:
MicroBac® microencapsulation technology, which significantly improves the survival of bacteria when traveling through the acidic environment of the stomach and survival in the gastrointestinal tract, ensuring that, with the same amount of bacteria in the dose, their effectiveness is 5 times higher than in other products. MicroBac® is a PROBIOTICAL S.P.A. registered trademark.
3Phase® cap technology ensures that bacteria are separated from the oil and only mix at the moment of opening the product, maintaining bacterial viability and activity until opening, and ensuring product quality throughout the shelf life. 3Phase® is a registered trademark of Bormioli Pharma S.P.A.
The composition is recognized by doctors. The Digestive Diseases Society recognizes the combination of LYLBIOTIC Drops with lacto and bifidobacteria, confirming it with the Digestive Diseases Society logo.
LYLBIOTIC Drops combines the particularly valuable for infants and children strains of Lacticaseibacillus rhamnosus GG, Limosilactobacillus reuteri LRE02 and Bifidobacterium breve BR03™️ bacteria.
Dietary supplement (probiotics). The daily dose contains 1 billion microencapsulated lactic acid and bifidobacteria, which are naturally found in the intestinal microbiota.
The effectiveness of the product is ensured by 2 innovative technologies:
MicroBac® microencapsulation technology, which significantly improves the survival of bacteria when traveling through the acidic environment of the stomach and survival in the gastrointestinal tract, ensuring that, with the same amount of bacteria in the dose, their effectiveness is 5 times higher than in other products. MicroBac® is a PROBIOTICAL S.P.A. registered trademark.
3Phase® cap technology ensures that bacteria are separated from the oil and only mix at the moment of opening the product, maintaining bacterial viability and activity until opening, and ensuring product quality throughout the shelf life. 3Phase® is a registered trademark of Bormioli Pharma S.P.A.